New Leaf Venture Partners’s Alder Biopharmaceuticals ALDR Stock Holding History

New Leaf Venture Partners’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-171,364	Closed	-$1.96M	–	18
2017 Q4	$1.96M	Hold	171,364	–	–	0.92%	14
2017 Q3	$2.1M	Hold	171,364	–	–	0.97%	12
2017 Q2	$1.96M	Sell	171,364 -57,064	-25%	-$1.05M	1.38%	13
2017 Q1	$4.75M	Hold	228,428	–	–	2.43%	8
2016 Q4	$4.75M	Sell	228,428 -2,526	-1%	-$65.7K	3.4%	9
2016 Q3	$7.57M	Buy	230,954 +40,148	+21%	+$1.22M	5.45%	6
2016 Q2	$4.76M	Sell	190,806 -57,000	-23%	-$1.54M	4.1%	8
2016 Q1	$6.07M	Sell	247,806 -252,592	-50%	-$5.85M	5.49%	7
2015 Q4	$16.5M	Sell	500,398 -164,385	-25%	-$5.56M	11.06%	4
2015 Q3	$21.8M	Buy	664,783 +7,000	+1%	+$298K	18.89%	2
2015 Q2	$34.8M	Buy	657,783 +24,490	+4%	+$891K	23.09%	1
2015 Q1	$18.3M	Buy	633,293 +409,740	+183%	+$11.2M	12.41%	4
2014 Q4	$6.5M	Buy	+223,553	New	+$4.01M	3.16%	7

Other funds holding ALDR

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New Leaf Venture Partners's ALDR Position: Q1 2018 in Review

New Leaf Venture Partners sold out of Alder Biopharmaceuticals (ALDR) in Q1 2018, closing a stake of 171,364 shares — an estimated $1.96M sold.

New Leaf Venture Partners first reported a position in ALDR in Q4 2014 and held it in 13 quarters. The position peaked at $34.8M in Q2 2015. 135 funds tracked by Wall St. Rank hold ALDR as of Q1 2018.

New Leaf Venture Partners reported no remaining Alder Biopharmaceuticals position as of Q1 2018 after selling out during the quarter.
New Leaf Venture Partners sold 171,364 Alder Biopharmaceuticals shares in Q1 2018, an estimated $1.96M.
New Leaf Venture Partners first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 13 quarters.
New Leaf Venture Partners's Alder Biopharmaceuticals position peaked at $34.8M in Q2 2015.
135 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2018.

Based on New Leaf Venture Partners's 13F filing for Q1 2018, filed 15 May 2018.